Deepinder Goyal invests $25M in Continue Research, his longevity venture

Eternal founder Deepinder Goyal pledged $25 M to Continue Research, a longevity venture advancing studies in aging, wellness, sleep, and nutrition. The initiative will fund early‑stage projects in health optimization and preventive science. Focused on “conscious evolution,” Goyal supports researchers developing advanced biotech and tracking tools. Operating independently of Eternal, it reflects his growing commitment to deep science and human health innovation.